Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma IncfiledCriticalAventis Pharma Inc
Publication of AR027225A1publicationCriticalpatent/AR027225A1/es
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invencion consiste en un pseudopolimorfo de hidrocarburo de (-)cis-2-(2-clorofenil)-5,7-dihidroxi-8[4R-(3S-hidroxi-1-metil)piperidinil]4H-1-benzopiran -4-ona, un mlétodo para su obtencion, una composicion farmacéutica y métodos para la ut ilizacion del pseudopolimorfo, que es un agenteinmunomodulador y antiinflamatorio, así como inhibidor de quinasas.
ARP010100185A2000-01-182001-01-17Pseudopolimorfo de (-)-cis-2-(2-clorofenil)-5,7-dihidroxi-8[4r(3s-hidroxi-1-metil)piperdinil]-4h-1-benzopiran-4-ona
AR027225A1
(es)
Industriel fremgangsmåde til fremstilling af 17-hydroxy-6-beta, 7-beta, 15-beta, 16-beta-bismethylen-3-oxo-17-alpha-pregn-4-en-21-carboxylsyre-gamma-lacton og nøglemellemprodukter for denne fremgangsmåde